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Abstract
Background: Decreased heart rate variability (HRV) is associated with a higher risk of mortality. Overall, postmenopausal
women have lower levels of HRV than premenopausal women, which may be additionally complicated by lifestyle related
behaviors such as physical inactivity and obesity. Though cardiorespiratory exercise training increases HRV, little is known
regarding the exercise dose necessary to promote this improvement.
Methodology/Principal Findings: Our primary aim was to measure HRV in post-menopausal women following 6-months of
exercise training. We examined supine resting HRV in 373 post-menopausal women (45–75 y) after 6-months of randomly
assigned and double-blinded administered exercise training exercise training at 50%, 100% and 150% of the NIH Consensus
Development Panel’s recommended minimal physical activity level. This corresponded to 4, 8, or 12 kcal/kg per week (KKW)
of energy expenditure. At baseline, we observed no significant differences in HRV or hormone replacement use between
treatment groups. However, we did observe that Caucasian women and those taking antidepressant medications had lower
levels of baseline HRV. After 6-months of exercise intervention, we observed a dose dependent increase in all
parasympathetically derived time and frequency domain measurements across exercise groups after adjustment for age,
ethnicity, antidepressants, and baseline rMSSD (all, P,0.001). For example, the parasympathetic index rMSSD was greater
than control (23.1961.0) for the 4-KKW (25.9860.8; P = 0.14), 8-KKW (27.6661.0; P,0.05), and 12-KKW (27.4060.0; P,0.05)
groups at follow-up.
Conclusions/Significance: Moderate intensity exercise training exercise is sufficient to improve HRV in previously sedentary
postmenopausal women in a dose-dependent manner, as 4-KKW is insufficient to improve parasympathetic indices of HRV,
while 12-KKW conferred no greater improvement than 8-KKW.
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Citation: Earnest CP, Lavie CJ, Blair SN, Church TS (2008) Heart Rate Variability Characteristics in Sedentary Postmenopausal Women Following Six Months of
Exercise Training: The DREW Study. PLoS ONE 3(6): e2288. doi:10.1371/journal.pone.0002288
Editor: Jose AL Calbet, University of Las Palmas de Gran Canaria, Spain
Received March 4, 2008; Accepted April 16, 2008; Published June 4, 2008
Copyright: ß 2008 Earnest et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The DREW study as financially supported by in part by American Heart Association Texas Affiliate award 02651404; the National Institutes of Health
grant HL-66262 and an exercise equipment donation from Life Fitness (Schiller Park, IL).
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: conrad.earnest@pbrc.edu

is one of the two leading causes of death in women [6,7]. A lifestyle
behavior that has a significant affect on the metabolic processes
surrounding CV disease is cardiorespiratory exercise training.
Current recommendations from the National Institutes of
Health (NIH) Consensus Development Panel recommend that
women attain a minimal level of moderate intensity activity such
as walking briskly for 30 minutes [8]. In a recent report, we
observed significant improvements in peak aerobic power for
varying doses of exercise in postmenopausal women obtaining
,50%, 100%, and 150% of the NIH recommendation [9]. Crosssectional reports, as well as reports in cardiac rehabilitation,[10]
suggest that regular exercise training improves HRV; however,
exercise training studies elaborating on the dose necessary to affect
beneficial HRV changes are not clear [11,12,13,14]. Limited
exercise training studies conducted on postmenopausal women

Introduction
Menopause represents a key transition period in a woman’s
health. A fundamental etiology associated with menopause is the
intricate link between estrogen metabolism and the autonomic
nervous system. Autonomic nervous system balance can be
assessed non-invasively via the use of heart rate variability
(HRV). While a thorough review of HRV can be obtained
elsewhere,[1] HRV is clinically useful because reduced HRV is
associated with an increased risk of CV disease, type II diabetes
and insulin resistance and has been shown to be reduced in
postmenopausal women as compared with premenopausal women
[2,3,4,5]. Equally, the assessment of HRV in postmenopause is
important because cardiovascular (CV) disease typically occurs
later in women than in men; yet, the fact remains that CV disease
PLoS ONE | www.plosone.org
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Gas-exchange variables (VO2, CO2 production, ventilation, and
respiratory exchange ratio [RER]) were averaged every 15 s.
Heart rate was measured directly from the ECG monitoring
system. Ratings of perceived exertion (RPE) were obtained using
the 20-point Borg scale. Fitness was defined as the mean of two
exercise test assessments at both baseline and 6 months. The
reproducibility of the two fitness tests (VO2abs) was examined and
characterized by an intraclass correlation of 0.88 at both baseline
and follow-up testing.

using small sample sizes (N,10) report no change in HRV after
exercise training [12,13,14]. However, an observational study by
Reland et al. has shown that postmenopausal women exhibiting
high levels of physical activity also exhibit high levels of
parasympathetic indices assessed by HRV [15]. Recently, we
reported an improvement in HRV characteristics accompanying
an 8-week exercise training intervention period [16]. Given the
aforementioned observations, we hypothesized that HRV would
exhibit a dose effect following 6-months of exercise training in
postmenopausal women. To test our hypothesis, we examined the
HRV response of women participating in the Dose-Response to
Exercise in Women study (DREW) who participated in 6-months
of strictly monitored, moderate intensity exercise training at
approximately 50%, 100%, and 150% of the minimal NIH Panel’s
recommendation for physical activity.

Daily Physical Activity and Exercise Training
To assess potential changes in non-supervised physical activity,
all randomized participants wore a step counter (Accusplit Eagle,
Japan) to record their daily steps. Exercisers removed their step
counter during supervised exercise sessions. Cardiovascular
exercise training consisted of having women expend 4, 8, or
12 kcal/kg per week (KKW). During their exercise training
sessions, women alternated exercise training using a recumbent
cycle ergometer or treadmill. The target training intensity for each
exercise training session was 50% of each woman’s VO2max for
each exercise modality. We used a computer-controlled exercise
training management that allowed us to input of relevant data
points on each woman (week of exercise, KKW dose according to
group assignment, their HR associated with 50% VO2max, training
HR zone, body weight, and number of visits per week). The
computer then provided us with the appropriate power output
(PO) for the cycle ergometer, and the correct speed and grade for
the treadmill. By knowing the exact PO for the cycle ergometer
and the treadmill, the total kilocalories expended each minute and
the time needed to reach the target energy expenditure for the
exercise session or for the week can be calculated. The duration of
each individual session depends on the number of visits required to
reach the target KKW. To monitor the participant’s caloric
expenditure over the course of 6 months, we created a weekly
tracking report, which was used to track and make calculate
caloric adjustments. The number of calories expended per session
was adjusted each week, within the limits of the study design so
that the total number of calories expended is equal to the total
number prescribed per week for the 24-wk program. This report
also averaged the number of visits per week so that we can
determine whether the participants are exercising at least two, but
no more than four, sessions each week.
During exercise, HR is monitored every 3–6 min using a Polar
HR monitor (Polar Vantage XL and Polar Vantage NV). The
target HR was used to monitor each woman’s performance during
each session to ensure that she was exercising at the proper
intensity. Monitoring HR allowed us to control exercise intensity
and document the specific amount of exercise done during each
session. As women improved their fitness, they worked at gradually
higher PO and spent less time to expend the required KKW. We
contacted participants if they missed a scheduled session so that
arrangements could be made to bring them back on schedule as
soon as possible. As previously reported, the non-exercise training
control group maintained their current level of activity during the
trial period and showed no significant increase in physical activity
[9].Those women in the exercise training groups adhered well to
their prescribed exercise training and attended 92% of their
exercise training sessions [9].

Methods
We have recently published a complete description of the
DREW design, methods, and primary outcomes for our current
cohort. These two papers detail how we derived the sample size for
our main outcomes, the randomization sequence and allocation
procedures, blinding techniques, recruitment and adverse events
[9,17]. In brief, DREW is a randomized, dose-response, doubleblind, exercise training trial that complies with Declaration of
Helsinki and comprised of a non-exercise control group and three
exercise training groups exercising at incremental doses (50%,
100%, and 150%) of the minimal NIH Panel’s recommendation
for energy expenditure. The study was originally reviewed
annually by The Cooper Institute and subsequently approved by
the Pennington Biomedical Research Center IRB for the
continued analysis and publication of pertinent research findings.
Prior to participation, all participants signed a written informed
consent document outlining the procedures involved in the
DREW study. The primary outcomes for DREW study included
peak aerobic power and resting blood pressure [9,17]. The data
presented herein is the result of a secondary analysis examining the
potential HRV response to exercise training. The supporting
CONSORT checklist for this trial is available as Checklist S1, and
the protocol is outlined in [17].
After an initial run-in period, we randomized 464 postmenopausal women (45–75 y) to 1 of 3 exercise training groups or a
non-exercise control for a 6-month intervention period. Study
participants were sedentary (exercising,than 20 minutes; ,3 d/
wk; ,8000 steps/d assessed over the course of 1 week), overweight
or obese (BMI 25.0 to 43.0 kg/m2), and had a systolic blood
pressure of 120.0 to 159.9 mm Hg. As previously reported, there
was no difference in this cohort at baseline or following our
intervention for fasting measures of cholesterol, triglycerides, and
glucose [9]. We excluded women who had a history of stroke,
heart attack, or any serious medical condition that prevented
participants from adhering to the protocol or exercising safely.
Following baseline testing, inclusive of HRV (see below),
participants were randomized into respective treatment groups.

Fitness Testing
We conducted our fitness testing using a Lode Excalibur Sport
cycle ergometer (Groningen, Netherlands), an electronic, rateindependent ergometer. Participants cycled at 30 Watts (W) for
2 min, 50 W for 4 min, followed by increases of 20 W every 2 min
until they could no longer maintain a pedal cadence of 50 rpm.
Breath-by-breath respiratory gases were measured using a
Parvomedics True Max 2400 Metabolic Measurement Cart.
Volume and gas calibrations were conducted before each test.
PLoS ONE | www.plosone.org

Heart Rate Variability
We examined HRV between 06:30 a.m. and 11:00 a.m. for
25 minutes in a semi-dark room (22–23uC) following a 12-hour
fast. Participants abstained from consuming caffeine-containing
products and alcoholic beverages for 12 hours and heavy exercise
2
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pairwise comparisons between the exercise training groups vs. the
control group using a Dunnett-Hsu post-hoc assessment. The
Dunnett-Hsu test allows for specific multiple pair-wise comparisons while still protecting against type I statistical errors. Between
group differences at baseline and follow-up in prevalence were
examined using Chi-square tests. We also used a subgroup analysis
to compare dose-response effects across predefined baseline groups
with significance of interactions relationships between variables
were tested using a Spearman correlation analysis and denoted as
rs. All reported P values are two-sided (P,0.05). All analyses were
performed using SAS version 9.1 (Cary, NC).

for 48 hours. We controlled respiration rate using a metronome at
a fixed rate of 12 breaths/min (0.2 Hz). HRV measurements were
conducted at the same time (61 hour) of day for each assessment
period. We used a two-channel ECG signal detected by a Polar
Heart Rate Monitor and transmitted online to a PC through Polar
Advantage Interface receiver. QRS timing was fixed at 1 ms. The
computer program labeled each QRS complex, and the resulting
signal was filtered to eliminate ectopic beats and artifact edited and
replaced with an average value. Segments containing .15%
artifact ectopy were interpreted as premature beats and were
excluded from our data analysis [18]. We quantified HRV from
the last 5 minutes of R–R interval recording.
For our primary outcome measurement, we examined the
parasympathetic nervous system by calculating the square root of
the mean of the sum of the squares of differences between adjacent
R–R intervals (rMSSD). rMSSD is considered to be a stable
measure of parasympathetic modulations in heart rate [1]. As a
secondary measurement of mixed signaling, we also calculated the
standard deviation of all R–R intervals (SDNN), which reflects the
cyclic components responsible for variability in the period of
recording and reflective of both sympathetic and parasympathetic
tone. As a tertiary aim, we analyzed frequency domain in three log
normalized frequency bands define as: high frequency power (HF;
0.15–0.40 Hz), low frequency power (LF; 0.04–0.15 Hz), very low
frequency power (VLF; 0.0033–0.04 Hz), and total frequency
power (PT; 0.00–0.40 Hz). The filtering techniques are described
in previous reports [18,19].

Results
Baseline Heart Rate, Medication, and Physiologic vs. HRV
Correlation Characteristics
We have presented a schematic CONSORT flowchart our
HRV analysis in Figure 1. Baseline health characteristics are
presented in Table 1 and an examination of parasympathetic
levels (rMSSD) by ethnicity, smoking status and medication use in
Table 2. Overall, we were able to successfully obtain HRV
measurements on 373 individuals at follow up. In our analysis of
baseline characteristics (Table 2), we observed significant differences for ethnicity (P,0.0001) and antidepressant medication use
(P,0.002). Post-hoc assessments revealed that African American
women had statistically higher levels of rMSSD vs. Caucasian
women (P,0.0001). Spearman correlations characteristics for
various physiologic variables and HRV indices are presented in
Table 3. With the exception of VLF power, we observed small yet
significant correlations between age and all indices of HRV. When
analyzing HRV change from baseline to follow-up we did not
observe any significant correlations between most HRV parameters and changes in fitness (VO2 L/min), weight, and BMI.
There were three exceptions as we did observe a negative
correlation between BMI and SDNN (rs = 20.1; P,0.05), VLF
(rs = 20.12; P,0.0004), and body weight (rs = 20.11; P,0.02).

Statistical analysis
We used a generalized linear model (GLM) to analyze the
influences of the differing doses of exercise training on HRV
characteristics. We adjusted all our outcomes among the
randomization groups for select specified covariates including
baseline HRV, race, and the use of antidepressant medication.
When our GLM demonstrated a significant overall statistical effect
and a significant treatment group effect, we further explored

Figure 1. DREW Heart Rate Variability Assessment: Schematic diagram represents CONSORT flow chart of the DREW heart rate
variability study analysis.
doi:10.1371/journal.pone.0002288.g001
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Table 1. Baseline Characteristics.

Total Cohort
(N = 373)

Control (n = 87)

4 KKW (n = 125)

8 KKW (n = 77)

12 KKW (n = 84)

57.5 (6.3)

57.5 (5.8)

58.2 (6.4)

57.4 (6.4)

56.7 (6.3)

Demographics
Age, mean (SD) y
Ethnicity (%)
Caucasian

67

68

65

62

72

African American

27

24

29

30

26

Hispanic or Other

6

8

6

8

2

Weight (kg)

84.5 (12.0)

86.4 (12.4)

83.3 (11.4)

85.2 (6.4)

83.8 (11.6)

BMI (kg/m2)

31.8 (3.7)

32.3 (3.9)

31.4 (3.6)

32.1 (3.9)

31.4 (3.6)

Waist circumference (cm)

101.2 (11.5)

103.4 (11.8)

100.2 (10.8)

102.5 (11.9)

99.2 (11.7)

1.31 (0.2)

1.34 (0.3)

1.29 (0.2)

1.29 (0.2)

1.33 (0.2)

Systolic

139.6 (13.0)

142.1 (12.3)

138.4 (13.2)

139.8 (13.7)

138.6 (12.9)

Diastolic

80.9 (8.6)

80.7 (7.9)

80.4 (9.1)

80.9 (8.6)

81.8 (8.5)

LDL-C (mg/dL)

118.4 (26.4)

117.3 (25.9)

116.9 (27.6)

118.0 (25.4)

121.9 (26.3)

HDL-C (mg/dL)

57.5 (14.3)

56.9 (14.2)

58.1 (14.4)

57.3 (15.8)

57.2 (13.0)

Antihypertensive

22

23

26

34

31

Thyroid

22

16

10

18

20

Antidepressant

19

18

18

18

21

Hyperlipidemic

22

16

18

14

11

Hormone Replacement Therapy

46

49

45

45

46

Never

59

55

62

61

54

Past

36

39

33

35

38

Current

6

6

5

4

8

Anthropometry

Cardiovascular
VO2max (L/min)
Blood pressure (mmHg)

Hematology*

Medication history (%)

Smoking (%)

Abbreviations: LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; HRT, hormone replacement therapy.
To convert LDL-C and HDL-C to mmol/L multiply by 0.0259.
doi:10.1371/journal.pone.0002288.t001

*

versus the control group for the 8-KKW and 12-kcal KKW
treatment conditions (both, P,0.05). Post hoc comparisons for LF,
VLF, and PT showed each HRV index to be greater than the
control group for the 4-KKW, 8-KKW, and 12-KKW treatment
conditions (all, P,0.05). No statistical effects were noted for the
LF:HF ratio.

Resting Heart Rate and HRV Analyses
We present the HR, time, and frequency domain analyses in
Table 4. All values represent the adjusted least squared means
covaried for baseline value, age, antidepressant use, and ethnicity.
Our primary GLM analyses for resting HR showed a statistically
significant time effect for resting HR (P,0.0001), but not for
treatment group effect (P = 0.10) after 6 months of exercise
training. Thus, we found no specific exercise training effect despite
a trend for a reduction in resting HR. For our time domain HRV
measurements, we observed a significant main statistical effect for
rMSSD and SDNN (all, P,0.0001) and for treatment group (all,
P,0.006). Post hoc comparisons revealed that rMSSD for the 8KKW and 12-KKW exercise training conditions were greater
than the control after 6 months (P,0.05). However, our post-hoc
assessment only showed a significant statistical difference in SDNN
for the 8-KKW treatment versus control (P,0.05).
For the frequency domain analysis, we observed a significant
main statistical effect for the HFLn, LFLn, VLF, and PT
components (all, P,0.001) and for treatment group (all,
P,0.002). Post hoc assessment revealed that the HF index of
HRV denoting parasympathetic tone was significantly greater
PLoS ONE | www.plosone.org

Discussion
The primary finding from our study is that moderate intensity
exercise training improves HRV characteristics in previously
sedentary, overweight or obese postmenopausal women. To our
knowledge, this is the largest clinically controlled exercise training
trial examining this question and the only study examining the
dose response of exercise training and HRV. Of particular interest
is that these effects appear to be dose-related regarding
parasympathetic tone (i.e., rMSSD and HF) as only women
exercising at or above the NIH recommendation exhibited a
positive change in these HRV characteristics. The same pattern
was present for SDNN; however, SDNN represents mixed
sympathetic and parasympathetic signaling which makes the
4
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interpretation of this index more difficult. These findings have
important implications for women entering into and completing
menopause.
Normal aging influences a variety of indices related to CV
circulation including the adrenoreceptor responsiveness and
baroflex sensitivity [20,21]. As it pertains to HRV, parasympathetic tone shifts to a lower range [22,23]. Though parasympathetic tone is generally higher in women than men, aging reduces
the difference between the two genders whereby changes in HRV
begin approximately at menopause [7,24,25]. A hallmark feature
of exercise training is an improvement in CV dynamics, inclusive
of an improvement in the neuroregulatory aspects of cardiac
regulation through the sinoatrial node [26,27,28,29]. Further, high
levels of cardiorespiratory fitness are associated with higher HRV
characteristics in endurance-exercise training young and older
men as denoted by various indices including LF, HF total power,
SDNN, and rMSSD [30,31,32,33]. However, this relationship is
not as clear in older women where some studies show no difference
in HRV characteristics, while others report an improvement in
women exhibiting higher physical activity levels [14,15,34]. This is
important clinically as a moderate level of physical activity is
recommended for an aging population during a time when
physiologic function and physical activity levels are waning
[35,36]. Our findings affirm the theory that physical activity
facilitates improvements HRV in older women and that the
quantity of exercise training necessary to affect such an
improvement is relatively modest.
Previous cross-sectional studies helped to define the question
evaluated our the current study. In a recent report, Reland et al.
categorized older women into three groups: low activity
(1000 kcal/week), moderate activity (.1000–2000 kcal/week),
and high activity (.2000 kcal/week) and found that women in
the high activity group who participated in chronic physical
activity demonstrated an increase in parasympathetic indices of
HRV [15]. A recent prospective study by Britton et al. also found
that women who avoided being placed in the lowest/adverse
quartile of HRV function and HR during 5.6 years of follow-up
are most strongly influenced by baseline exercise training, body
mass index, cholesterol, and blood pressure [37]. While these
investigations support the concept that physical activity improves
HRV, they do not adequately reflect the efficacy of using exercise
training as an intervention to improve HRV.
Earlier literature describing the use of exercise training to
modulate HRV in women is limited and difficult to interpret due
to variances in study protocol participant age, length, small sample
sizes and the exercise training intensity used for the intervention.
Davy et al reported that 12 weeks of aerobic exercise at 70% of
maximal heart rate (,50–55% VO2max) was insufficient to
improve HRV in eight postmenopausal women [12]. In contrast,
Ito et al observed a significant improvement in HRV characteristics following 8 weeks of exercise training in mildly obese younger
women (45.964 y; [38]) In the only study we are aware of using a
longer exercise training intervention, Stein et al observed an
improvement in HRV characteristics for older women (6664 y)
exercising at 70% of VO2max (,80–85% HRmax). From these
studies, one could surmise that intensity and study length are
important factors for examining HRV changes in women;
however, the results of these trials may create confusion regarding
the effectiveness of exercise training for improving HRV in
women.
Perhaps the most simplistic explanation surrounding previous
findings is that these trials were performed with small sample sizes
and may have been statistically underpowered to adequately
identify changes in HRV relative to exercise training. In our

Table 2. Baseline Heart Rate Variability (rMSSD)
Characteristics by Ethnicity, Smoking Habitus, and Medication
Use.

n

Mean (SD)

P
,0.0001*

Ethnicity
Caucasian

248

21.14 (10.2)

African–American

102

27.13 (13.4)

Hispanic or Other

23

24.09 (13.9)

218

23.37 (12.1)

Past

134

22.03 (11.0)

Current

21

24.52 (11.3)

Not taking

268

23.32 (11.9)

Taking

104

21.87 (11.1)

Not taking

314

23.09 (11.4)

Taking

58

21.94 (12.9)

,0.0001{

Smoking

0.47

Never

Antihypertensive

0.26

Thyroid

0.47

,0.002*

Antidepressant
Not taking

302

23.85 (11.5)

Taking

71

19.14 (11.6)

Not taking

315

23.04 (11.5)

Taking

57

22.21 (12.8)

Hyperlipidemic

0.6

Hormone Replacement
Therapy

0.16

Not taking

196

23.54 (11.3)

Taking

170

22.03 (12.1)

*

Significant overall statistical effect.
Significantly different than Caucasian.
Abbreviation: rMSSD; Root mean square successive difference of RR intervals.
doi:10.1371/journal.pone.0002288.t002
{

Table 3. Baseline Relationship between Physiologic
Characteristics and Indices of Heart Rate Variability.

Indices of Heart Rate Variability
Physiologic
Characteristic

Time Domain

Frequency Domain

Baseline

rMSSD

SDNN

HF

LF

Age, y

20.19*

20.15{

20.22{

20.111 20.07

VLF

Total

VO2max, L/min

0.04

0.07

0.05

0.08

0.0003 0.06

Weight, kg

20.02

20.04

20.02

20.02

20.04

20.03

BMI, kg/m2

0.02

0.00

0.02

0.02

20.04

0.01

20.18//

Data represent Spearman correlation coefficients.
Statistical notations are: (*) P,0.0002, ({) P,0.003, ({) P,0.001, (1) P,0.03), (//)
P,0.0004.
Abbreviations: SDNN, standard deviation of RR intervals; rMSSD, Root mean
square successive difference of RR intervals; HF, log high frequency spectral
power (0.15–0.40 Hz); LF, log low frequency spectral power (0.04–0.15 Hz); VLF,
log very low frequency spectral power (0.0033–0.04 Hz); PT, log total spectral
power frequency.
doi:10.1371/journal.pone.0002288.t003

PLoS ONE | www.plosone.org
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Table 4. Heart Rate Variability Outcome Measures at Follow-Up.

Heart Rate (b/min)

Control (n = 87)

4 KKW (n = 125)

8 KKW (n = 77)

12 KKW (n = 84)

64.8 (5.0)

63.9 (4.0)

63.0 (4.0)

63.2 (6.0)

23.19 (9.3)

25.98 (8.9)

27.66 (8.8){

Time Domain (ms)
rMSSD*,
SDNN

{

*, {

27.40 (9.2){

{

32.93 (10.1)

34.96 (10.1)

37.84 (8.8)

36.20 (10.1){

2

Frequency Domain (ms )
HFLn*,

{

5.20 (0.9)

5.40 (1.1)

5.56 (1.0){

5.49 (0.9){

LFLn*,

{

5.21 (0.9)

5.46 (1.1){

5.63 (1.0){

5.53 (0.9){

{

4.64 (0.9)

4.94 (1.1){

5.03 (1.0){

4.88 (0.9){

LF:HF Ratio

1.60 (2.0)

1.55 (2.2)

1.64 (2.0)

1.41 (1.8)

6.28 (0.9)

6.49 (1.1){

6.61 (1.0){

6.55 (0.9){

VLF*,

TotalLn*,

{

Data are mean (SD).
Analyses adjusted for age, ethnicity, and antidepressant medication use.
Statistical notations: (*) significant overall main effect (P,0.0001); ({) significant group effect (P,0.006); ({) significantly different from control (P,0.05).
Abbreviations: SDNN, standard deviation of RR intervals; rMSSD, Root mean square successive difference of RR intervals; HF, log high frequency spectral power (0.15–
0.40 Hz); LF, log low frequency spectral power (0.04–0.15 Hz); VLF, log very low frequency spectral power (0.0033–0.04 Hz); PT, log total spectral power frequency.
doi:10.1371/journal.pone.0002288.t004

current trial, parasympathetic tone significant increased following
6-months of exercise training at 8-KKW and 12-KKW. The two
most relevant points to be garnered from our findings are (1) that a
significant change in HRV does accompany longer periods of
exercise training consistent with the NIH recommendation and (2)
a greater level of energy expenditure may not be necessary to
achieve greater improvements in HRV. In essence, our findings
suggest a ‘‘threshold effect’’ regarding aerobic exercise training
and improvements in HRV. Nonetheless, we caution readers not
to misinterpret that 4-KKW is ineffective for improving HRV as
several indices of HRV were increased at the 4-KKW.
Unfortunately, the interpretation of these results is more difficult
to explain regarding the parasympathetic influence associated with
HRV. SDNN and LF power are thought to represent mixed
sympathetic and parasympathetic signaling and the physiologic
characteristics surrounding VLF are still a matter of debate [1]. It
has also been suggested that VLF is a ‘‘dubious’’ measurement
when using short-term recordings #5 minutes [1]. With respect to
the actual energy expenditure associated with exercising at 4KKW, changes in HRV may take a longer period to fully realize.
A final point to consider is whether an improvement in HRV is
actually protective. Specifically, does an improvement in HRV
carry with it the inherent assumption that the modification of
HRV translates directly into CV protection [1]? The paradox of
this question exists whereby it is largely accepted that exercise
training decreases CV mortality and regular exercise training is
capable of modifying autonomic balance [39,40,41,42].
We believe that improvements in HRV via exercise training
are likely to reduce the risk of mortality for several reasons. In
animal studies, dogs documented with a high mortality risk due
to the previous occurrence of ventricular fibrillation during
acute myocardial ischemia were randomly assigned to 6 weeks
of either daily exercise training or cage rest. After exercise
training, indices of HRV increased by 74% and all animals were
better able to survive an experimental ischemic challenge after
the exercise training period [43]. In humans, exercise training
also accelerates the recovery sympathovagal interaction and
improves patient prognosis in post-MI patients [44,45]. Though
each of the aforementioned studies has been reported in animal
and humans with CV disease, perhaps the most compelling
argument for protection is the observation that CV disease
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mortality is associated with a constellation of risk factors
[46,47]. Thus, even if modulating HRV through exercise
training does not directly affect mortality, per se, the practice
of CV exercise influences multiple risk factors associated with
CV disease due to its broad influence and on both the ANS and
CV system.
A primary strength of the DREW study is that it used a wellcontrolled dosage of exercise, with a high level of adherence.
Moreover, the exercise dose used in our study is easily
obtainable in sedentary women. The DREW study has
limitations because its sample is limited to sedentary postmenopausal women. We do not know if the results will apply to
other women or men. An interesting finding from our study is
that women exercising at a higher caloric expenditure (12KKW) did not experience greater improvements in HRV than
women exercising at 8-KKW. Finally, our findings should not
dissuade women from exercise training at a lower dose of they
are not able to achieve the minimum level of exercise training
necessary to improve HRV. Given the global effects of aerobic
exercise training, HRV represents only one measure of CV risk,
which may ultimately show improvement accompanying longer
periods of exposure.

Supporting Information
Checklist S1 CONSORT Checklist
Found at: doi:10.1371/journal.pone.0002288.s001 (0.23 MB
PDF)
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